Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

0
Player Avatar 10cent (97.11) Submitted: 1/11/2013 8:17:34 PM : Outperform Start Price: $25.43 QCOR Score: +66.00

High short interest. Speculation.

Member Avatar 10cent (97.11) Submitted: 2/27/2013 3:30:20 PM
Recs: 0

Bought in at $26.

Featured Broker Partners


Advertisement